Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-16,642
Closed -$60.1K 934
2026
Q1
$60.1K Buy
+16,642
New +$57.6K ﹤0.01% 630
2025
Q4
Sell
-19,816
Closed -$135K 712
2025
Q3
$135K Buy
+19,816
New +$164K 0.01% 539
2021
Q2
Sell
-329,731
Closed -$5.22M 297
2021
Q1
$5.22M Buy
+329,731
New +$5.94M 0.87% 27

Other funds holding LFMD

Atom Investors's LFMD Position: Q2 2026 in Review

Atom Investors sold out of LifeMD (LFMD) in Q2 2026, closing a stake of 16,642 shares — an estimated $60.1K sold.

Atom Investors first reported a position in LFMD in Q1 2021 and held it in 3 quarters. The position peaked at $5.22M in Q1 2021. 116 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • Atom Investors reported no remaining LifeMD position as of Q2 2026 after selling out during the quarter.
  • Atom Investors sold 16,642 LifeMD shares in Q2 2026, an estimated $60.1K.
  • Atom Investors first reported a position in LifeMD in Q1 2021 and held it in 3 quarters.
  • Atom Investors's LifeMD position peaked at $5.22M in Q1 2021.
  • 116 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on Atom Investors's 13F filing for Q2 2026, filed 14 Aug 2026.